Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase C delta (PKCδ) is a member of the protein kinase C (PKC) family, which consists of serine/threonine kinases involved in regulating diverse cellular processes. PKCδ belongs to the "novel" subfamily of PKCs, which are characterized by their activation through diacylglycerol (DAG) but not calcium ions. It plays critical roles in cell growth, differentiation, proliferation, and apoptosis, and participates in cellular responses to oxidative stress. Altered PKCδ function has been implicated in several human diseases including cancer, stroke, ischemic heart disease, diabetes mellitus, neurodegenerative disorders, and sepsis.
Protein phosphorylation; modulation of protein-protein interactions
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase C delta isozyme (PKCδ).